BridgeMD
New treatment option for HIV Prevention
Official title Intervention to Enhance PrEP Persistence
ClinicalTrials.gov ID: NCT06872307
What this study is testing
- What it's testing
- The investigators will conduct a fully powered randomized controlled trial (RCT) to test the effect of a patient navigation intervention for Black/African American (B/AA) men who have sex with men (MSM) on PrEP initiation, adherence and retention in care. B/AA men who have sex with men (MSM) are disproportionately impacted by the HIV/AIDS epidemic in the United States.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only. Healthy volunteers may be eligible.
You may be able to join if
- Aged 18 years and older
- Assigned male sex at birth
- Identify as Black/African American
- Report at least one male sex partner in the past 12 months
- Meet the CDC eligibility criteria for PrEP
You likely can't join if
- Under the age of 18
- Assigned female sex at birth
- Does not identify as Black/African American
- Has not had a male sex partner in the past 12 months
- Does not meet CDC eligibility criteria for PrEP
- Has taken PrEP within the last 30 days
See the full eligibility criteria
- Aged 18 years and older
- Assigned male sex at birth
- Identify as Black/African American
- Report at least one male sex partner in the past 12 months
- Meet the CDC eligibility criteria for PrEP
- Have not taken PrEP for at least 30 days
- Are HIV-negative based on antibody testing at the time of enrollment
- Understand and speak English
- Able to provide informed consent
- Agree to authorize study access to their EHR and pharmacy fill data. Eligible patients who are interested in participating will be consented and enrolled into the study.
- Under the age of 18
- Assigned female sex at birth
- Does not identify as Black/African American
- Has not had a male sex partner in the past 12 months
- Does not meet CDC eligibility criteria for PrEP
- Has taken PrEP within the last 30 days
- HIV-positive or inconclusive HIV status based on antibody testing at the time of enrollment
- Does not understand or speak English
- Unable to provide informed consent
- Does not agree to authorize study access to their EHR and pharmacy fill data.
The study team makes the final eligibility decision.
Where it's taking place
- Washington D.C., District of Columbia, United States
- Jackson, Mississippi, United States
- Providence, Rhode Island, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Washington D.C., District of Columbia, United States; Jackson, Mississippi, United States; Providence, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.